New York A 6393: Requires the department of labor to produce a report regarding summer youth employment programs

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A06393 Summary:

BILL NOA06393 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORPeoples-Stokes

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

&nbsp

Establishes a Center for Transplantation and Immunology Research at the University at Buffalo and Erie County Medical Center; provides the mission of the Center for Transportation and Immunology Research is to advance the longevity of kidney organ transplants through improved knowledge of immunology, pathology and therapeutics; grants authorization to apply for grants; makes an appropriation of $227,333.34 each year for three years.

Go to top A06393 Actions:

BILL NOA06393 

&nbsp

03/04/2025referred to higher education

01/07/2026referred to higher education

Go to topA06393 Committee&nbspVotes:

Go to topA06393 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA06393 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 6393

 2025-2026 Regular Sessions

 IN ASSEMBLY

 March 4, 2025
 ___________

 Introduced by M. of A. PEOPLES-STOKES -- read once and referred to the
 Committee on Higher Education

 AN ACT to establish a Center for Transplantation and Immunology Research
 at the University at Buffalo and Erie County Medical Center; and
 making an appropriation therefor

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Legislative determinations. Kidney disease in the United
 2 States is fast becoming epidemic in character. Due to the increasing
 3 incidence of both diabetes and hypertension in the general population,
 4 chronic renal disease affects an estimated 16.8% of adults aged 20 years
 5 and older. As of 2008, there were over 500,000 people on dialysis more
 6 than 300,000 of who have diabetes and hypertension as their underlying
 7 cause. The cost to society of treating end-stage renal disease (ESRD) in
 8 2008 was 39.46 billion dollars. The cost to the individual patient is a
 9 higher mortality and shorter life span at all ages compared to the
 10 general population. In the absence of effective therapies for chronic
 11 kidney disease, patients are left with the choice of either dialysis or
 12 transplantation.
 13 Kidney transplantation has become the treatment of choice for patients
 14 with end stage renal disease (ESRD) providing improved survival rates
 15 and a better quality of life. In addition, transplantation represents
 16 the most cost-effective form of ESRD therapy once the allograft survives
 17 more than 3 years. As immunosuppressive therapies for kidney transplan-
 18 tation evolved to include more potent and specific therapies, short-term
 19 (1 year) patient and graft survival rates have continuously improved. It
 20 is not unusual to expect 1 year success rates of over 90%. However,
 21 these short term improvements have not translated into improved longer
 22 survival rates. The expected survival of kidney transplants for living
 23 donors remains at 18-20 years and for deceased donor organs 8-10 years;
 24 rates which have not significantly improved over the past 20 years.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD01791-01-5

 A. 6393 2

 1 Currently, the most important challenge in renal transplantation is
 2 promoting the long-term kidney allograft function. Eventually many, if
 3 not all, transplanted kidneys develop a progressive fibrotic process
 4 that affects both the interstitium and vasculature. This renal fibrosis
 5 eventually leads to renal failure, an increased rate of cardiovascular
 6 disease and mortality and the need for reinstituting dialysis. Today,
 7 the most rapidly increasing group of patients requiring a new kidney
 8 transplant is those whose previous transplant has failed.
 9 It is becoming increasingly clear that there is no single cause of
 10 kidney transplant fibrosis rather this process culminates from a myriad
 11 of etiologies. One of the major challenges to delivering effective tran-
 12 splant care is the difficulty in assessing an individual's particular
 13 requirements for adequate immunosuppression. In of itself, too much
 14 immunosuppressive therapy in the form of calcineurin inhibitors leads to
 15 renal fibrosis and is felt to be a major